Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amn Healthcare Services (AMN) Receivables (2016 - 2025)

Amn Healthcare Services' Receivables history spans 16 years, with the latest figure at $382.6 million for Q4 2025.

  • For Q4 2025, Receivables fell 12.62% year-over-year to $382.6 million; the TTM value through Dec 2025 reached $382.6 million, down 12.62%, while the annual FY2025 figure was $382.6 million, 12.62% down from the prior year.
  • Receivables reached $382.6 million in Q4 2025 per AMN's latest filing, down from $391.1 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $979.7 million in Q1 2022 to a low of $382.6 million in Q4 2025.
  • Average Receivables over 5 years is $578.4 million, with a median of $567.9 million recorded in 2021.
  • Peak YoY movement for Receivables: surged 109.82% in 2021, then fell 29.81% in 2023.
  • A 5-year view of Receivables shows it stood at $789.1 million in 2021, then dropped by 14.38% to $675.6 million in 2022, then decreased by 7.72% to $623.5 million in 2023, then decreased by 29.78% to $437.8 million in 2024, then dropped by 12.62% to $382.6 million in 2025.
  • Per Business Quant, the three most recent readings for AMN's Receivables are $382.6 million (Q4 2025), $391.1 million (Q3 2025), and $387.8 million (Q2 2025).